Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...

Sodium-glucose cotransporter 2 inhibitors (eg, dapagliflozin) are understudied in kidney transplant recipients. A trial attempted to fill this knowledge gap.

A survey of practices that treat AYA patients with cancer showed that almost half of them screen for financial hardship, but few offer cancer-specific navigation. A survey of practices that treat AYAs ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos.

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.

(HealthDay News) — A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions, including death, dementia, and myocardial infarction (MI), according ...

Prevalence, treatment utilization described for hypertension, diabetes mellitus, obesity, LDL-C, and cigarette smoking.

Quality communication about end-of-life care ensures that medical treatments or interventions align with patients’ values and ...

After adjustment, light physical activity significantly linked to lower mortality in cardiovascular-kidney-metabolic syndrome ...

(HealthDay News) — For patients with primary solid tumors receiving cancer therapy, clonal hematopoiesis of indeterminate potential (CHIP) is associated with an increased risk for cardiovascular ...

(HealthDay News) — The Brain Care Score (BCS), a tool encompassing 12 modifiable risk factors, is associated with incident stroke in Black and White U.S. adults, with a larger effect size for Black ...